PATENT CLAIM ANALYSIS

Application Number: 15920690
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["548", "356100"]

Abstract:
The invention provides pyrazolyl guanidine compounds that inhibit F 1 F 0 -ATPase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.

Claim (Index 50):
The method of  claim 48 , wherein R 1  represents independently for each occurrence halogen or haloalkyl.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 90.0
- Lexical Diversity: 1.24242
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15421729', '13992255', '14800969', '14403787', '15896378']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7801325771356176
- 35 USC 102 Novelty (BERT): 0.5835055268204361
- Combined Prediction Score: 0.7604698721040994
- Mean Citation Score: 455.417124
- Max Citation Score: 484.4478
- Similarity Product: 420.5907384912729

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test